Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Breast Cancer

  Free Subscription


Articles published in Eur Radiol

Retrieve available abstracts of 45 articles:
HTML format
Text format



Single Articles


    August 2019
  1. KIM JY, Kim JJ, Hwangbo L, Lee JW, et al
    Diffusion-weighted MRI of estrogen receptor-positive, HER2-negative, node-negative breast cancer: association between intratumoral heterogeneity and recurrence risk.
    Eur Radiol. 2019 Aug 5. pii: 10.1007/s00330-019-06383.
    PubMed     Text format     Abstract available


    July 2019
  2. KETTUNEN T, Okuma H, Auvinen P, Sudah M, et al
    Peritumoral ADC values in breast cancer: region of interest selection, associations with hyaluronan intensity, and prognostic significance.
    Eur Radiol. 2019 Jul 29. pii: 10.1007/s00330-019-06361.
    PubMed     Text format     Abstract available


  3. BLANKS RG, Given-Wilson RM, Cohen SL, Patnick J, et al
    Correction to: An analysis of 11.3 million screening tests examining the association between recall and cancer detection rates in the English NHS breast cancer screening programme.
    Eur Radiol. 2019 Jul 5. pii: 10.1007/s00330-019-06307.
    PubMed     Text format     Abstract available


    June 2019
  4. KOH J, Park AY, Ko KH, Jung HK, et al
    Can enhancement types on preoperative MRI reflect prognostic factors and surgical outcomes in invasive breast cancer?
    Eur Radiol. 2019 Jun 11. pii: 10.1007/s00330-019-06236.
    PubMed     Text format     Abstract available


    May 2019
  5. HELLGREN RJ, Sundbom AE, Czene K, Izhaky D, et al
    Does three-dimensional functional infrared imaging improve breast cancer detection based on digital mammography in women with dense breasts?
    Eur Radiol. 2019 May 21. pii: 10.1007/s00330-019-06248.
    PubMed     Text format     Abstract available


  6. JEUKENS CRLPN, van Dijk T, Berben C, Wildberger JE, et al
    Evaluation of pressure-controlled mammography compression paddles with respect to force-controlled compression paddles in clinical practice.
    Eur Radiol. 2019;29:2545-2552.
    PubMed     Text format     Abstract available


  7. HA SM, Chae EY, Cha JH, Kim HH, et al
    Long-term survival outcomes in invasive lobular carcinoma patients with and without preoperative MR imaging: a matched cohort study.
    Eur Radiol. 2019;29:2526-2534.
    PubMed     Text format     Abstract available


  8. CHAE EY, Kim HH, Jeong JW, Chae SH, et al
    Decrease in interpretation time for both novice and experienced readers using a concurrent computer-aided detection system for digital breast tomosynthesis.
    Eur Radiol. 2019;29:2518-2525.
    PubMed     Text format     Abstract available


    March 2019
  9. UHLIG J, Uhlig A, Biggemann L, Fischer U, et al
    Diagnostic accuracy of cone-beam breast computed tomography: a systematic review and diagnostic meta-analysis.
    Eur Radiol. 2019;29:1194-1202.
    PubMed     Text format     Abstract available


  10. AASE HS, Holen AS, Pedersen K, Houssami N, et al
    A randomized controlled trial of digital breast tomosynthesis versus digital mammography in population-based screening in Bergen: interim analysis of performance indicators from the To-Be trial.
    Eur Radiol. 2019;29:1175-1186.
    PubMed     Text format     Abstract available


  11. GOTO M, Sakai K, Yokota H, Kiba M, et al
    Diagnostic performance of initial enhancement analysis using ultra-fast dynamic contrast-enhanced MRI for breast lesions.
    Eur Radiol. 2019;29:1164-1174.
    PubMed     Text format     Abstract available


    February 2019
  12. VREEMANN S, Dalmis MU, Bult P, Karssemeijer N, et al
    Amount of fibroglandular tissue FGT and background parenchymal enhancement BPE in relation to breast cancer risk and false positives in a breast MRI screening program : A retrospective cohort study.
    Eur Radiol. 2019 Feb 22. pii: 10.1007/s00330-019-06020.
    PubMed     Text format     Abstract available


  13. BLANKS RG, Given-Wilson RM, Cohen SL, Patnick J, et al
    An analysis of 11.3 million screening tests examining the association between recall and cancer detection rates in the English NHS breast cancer screening programme.
    Eur Radiol. 2019 Feb 4. pii: 10.1007/s00330-018-5957.
    PubMed     Text format     Abstract available


    January 2019
  14. HAN L, Zhu Y, Liu Z, Yu T, et al
    Radiomic nomogram for prediction of axillary lymph node metastasis in breast cancer.
    Eur Radiol. 2019 Jan 30. pii: 10.1007/s00330-018-5981.
    PubMed     Text format     Abstract available


  15. FAN M, Zhang P, Wang Y, Peng W, et al
    Radiomic analysis of imaging heterogeneity in tumours and the surrounding parenchyma based on unsupervised decomposition of DCE-MRI for predicting molecular subtypes of breast cancer.
    Eur Radiol. 2019 Jan 7. pii: 10.1007/s00330-018-5891.
    PubMed     Text format     Abstract available


    November 2018
  16. XIE T, Zhao Q, Fu C, Bai Q, et al
    Differentiation of triple-negative breast cancer from other subtypes through whole-tumor histogram analysis on multiparametric MR imaging.
    Eur Radiol. 2018 Nov 6. pii: 10.1007/s00330-018-5804.
    PubMed     Text format     Abstract available


  17. WARD L, Heller S, Hudson S, Wilkinson L, et al
    Parenchymal pattern in women with dense breasts. Variation with age and impact on screening outcomes: observations from a UK screening programme.
    Eur Radiol. 2018;28:4717-4724.
    PubMed     Text format     Abstract available


    October 2018
  18. LAMEIJER JRC, Coolen AM, Voogd AC, Strobbe LJ, et al
    Frequency and characteristics of contralateral breast abnormalities following recall at screening mammography.
    Eur Radiol. 2018;28:4205-4214.
    PubMed     Text format     Abstract available


    September 2018
  19. BOTSIKAS D, Bagetakos I, Picarra M, Da Cunha Afonso Barisits AC, et al
    What is the diagnostic performance of 18-FDG-PET/MR compared to PET/CT for the N- and M- staging of breast cancer?
    Eur Radiol. 2018 Sep 28. pii: 10.1007/s00330-018-5720.
    PubMed     Text format     Abstract available


  20. TARON J, Fleischer S, Preibsch H, Nikolaou K, et al
    Background parenchymal enhancement in pregnancy-associated breast cancer: a hindrance to diagnosis?
    Eur Radiol. 2018 Sep 18. pii: 10.1007/s00330-018-5721.
    PubMed     Text format     Abstract available


  21. BOSS A
    Editorial comment: cone-beam and phase contrast CT: new horizons in breast imaging?
    Eur Radiol. 2018;28:3729-3730.
    PubMed     Text format     Abstract available


  22. WIENBECK S, Fischer U, Luftner-Nagel S, Lotz J, et al
    Contrast-enhanced cone-beam breast-CT (CBBCT): clinical performance compared to mammography and MRI.
    Eur Radiol. 2018;28:3731-3741.
    PubMed     Text format     Abstract available


    August 2018
  23. JOUKAINEN S, Masarwah A, Kononen M, Husso M, et al
    Feasibility of mapping breast cancer with supine breast MRI in patients scheduled for oncoplastic surgery.
    Eur Radiol. 2018 Aug 17. pii: 10.1007/s00330-018-5681.
    PubMed     Text format     Abstract available


  24. SUO S, Zhang D, Cheng F, Cao M, et al
    Added value of mean and entropy of apparent diffusion coefficient values for evaluating histologic phenotypes of invasive ductal breast cancer with MR imaging.
    Eur Radiol. 2018 Aug 16. pii: 10.1007/s00330-018-5667.
    PubMed     Text format     Abstract available


  25. ROSSI F, Valdora F, Barabino E, Calabrese M, et al
    Muscle mass estimation on breast magnetic resonance imaging in breast cancer patients: comparison between psoas muscle area on computer tomography and pectoralis muscle area on MRI.
    Eur Radiol. 2018 Aug 7. pii: 10.1007/s00330-018-5663.
    PubMed     Text format     Abstract available


    July 2018
  26. VAN ZELST JCM, Tan T, Clauser P, Domingo A, et al
    Dedicated computer-aided detection software for automated 3D breast ultrasound; an efficient tool for the radiologist in supplemental screening of women with dense breasts.
    Eur Radiol. 2018;28:2996-3006.
    PubMed     Text format     Abstract available


    June 2018
  27. MATHIEU MC, Toullec A, Benoit C, Berry R, et al
    Preclinical ex vivo evaluation of the diagnostic performance of a new device for in situ label-free fluorescence spectral analysis of breast masses.
    Eur Radiol. 2018;28:2507-2515.
    PubMed     Text format     Abstract available


  28. SCHAEFGEN B, Heil J, Barr RG, Radicke M, et al
    Initial results of the FUSION-X-US prototype combining 3D automated breast ultrasound and digital breast tomosynthesis.
    Eur Radiol. 2018;28:2499-2506.
    PubMed     Text format     Abstract available


  29. HU Y, Yang Y, Gu R, Jin L, et al
    Does patient age affect the PPV3 of ACR BI-RADS Ultrasound categories 4 and 5 in the diagnostic setting?
    Eur Radiol. 2018;28:2492-2498.
    PubMed     Text format     Abstract available


  30. ROMERO MARTIN S, Raya Povedano JL, Cara Garcia M, Santos Romero AL, et al
    Prospective study aiming to compare 2D mammography and tomosynthesis + synthesized mammography in terms of cancer detection and recall. From double reading of 2D mammography to single reading of tomosynthesis.
    Eur Radiol. 2018;28:2484-2491.
    PubMed     Text format     Abstract available


    May 2018
  31. MALL S, Noakes J, Kossoff M, Lee W, et al
    Can digital breast tomosynthesis perform better than standard digital mammography work-up in breast cancer assessment clinic?
    Eur Radiol. 2018 May 30. pii: 10.1007/s00330-018-5473.
    PubMed     Text format     Abstract available


  32. CHEN BB, Lu YS, Yu CW, Lin CH, et al
    Imaging biomarkers from multiparametric magnetic resonance imaging are associated with survival outcomes in patients with brain metastases from breast cancer.
    Eur Radiol. 2018 May 16. pii: 10.1007/s00330-018-5448.
    PubMed     Text format     Abstract available


  33. VAN DER VELDEN BHM, Sutton EJ, Carbonaro LA, Pijnappel RM, et al
    Contralateral parenchymal enhancement on dynamic contrast-enhanced MRI reproduces as a biomarker of survival in ER-positive/HER2-negative breast cancer patients.
    Eur Radiol. 2018 May 7. pii: 10.1007/s00330-018-5470.
    PubMed     Text format     Abstract available


  34. WATANABE G, Itoh M, Duan X, Watabe H, et al
    (18)F-fluorodeoxyglucose specimen-positron emission mammography delineates tumour extension in breast-conserving surgery: Preliminary results.
    Eur Radiol. 2018;28:1929-1937.
    PubMed     Text format     Abstract available


    April 2018
  35. KIM JY, Kim JJ, Kim S, Choo KS, et al
    Diffusion tensor magnetic resonance imaging of breast cancer: associations between diffusion metrics and histological prognostic factors.
    Eur Radiol. 2018 Apr 30. pii: 10.1007/s00330-018-5429.
    PubMed     Text format     Abstract available


  36. KIM WH, Cho N, Kim YS, Yi A, et al
    Mammographic density changes following discontinuation of tamoxifen in premenopausal women with oestrogen receptor-positive breast cancer.
    Eur Radiol. 2018 Apr 6. pii: 10.1007/s00330-017-5293.
    PubMed     Text format     Abstract available


    March 2018
  37. SANABRIA SJ, Goksel O, Martini K, Forte S, et al
    Breast-density assessment with hand-held ultrasound: A novel biomarker to assess breast cancer risk and to tailor screening?
    Eur Radiol. 2018 Mar 19. pii: 10.1007/s00330-017-5287.
    PubMed     Text format     Abstract available


  38. KIM SY, Shin J, Kim DH, Kim EK, et al
    Correlation between electrical conductivity and apparent diffusion coefficient in breast cancer: effect of necrosis on magnetic resonance imaging.
    Eur Radiol. 2018 Mar 6. pii: 10.1007/s00330-017-5291.
    PubMed     Text format     Abstract available


    January 2018
  39. KIM SY, Cho N, Shin SU, Lee HB, et al
    Contrast-enhanced MRI after neoadjuvant chemotherapy of breast cancer: lesion-to-background parenchymal signal enhancement ratio for discriminating pathological complete response from minimal residual tumour.
    Eur Radiol. 2018 Jan 29. pii: 10.1007/s00330-017-5251.
    PubMed     Text format     Abstract available


  40. LI X, Gao H, Chen Z, Zhang L, et al
    Diagnosis of breast cancer based on microcalcifications using grating-based phase contrast CT.
    Eur Radiol. 2018 Jan 26. pii: 10.1007/s00330-017-5158.
    PubMed     Text format     Abstract available


  41. HORVAT JV, Durando M, Milans S, Patil S, et al
    Apparent diffusion coefficient mapping using diffusion-weighted MRI: impact of background parenchymal enhancement, amount of fibroglandular tissue and menopausal status on breast cancer diagnosis.
    Eur Radiol. 2018 Jan 12. pii: 10.1007/s00330-017-5202.
    PubMed     Text format     Abstract available


    December 2017
  42. RODRIGUEZ-RUIZ A, Gubern-Merida A, Imhof-Tas M, Lardenoije S, et al
    One-view digital breast tomosynthesis as a stand-alone modality for breast cancer detection: do we need more?
    Eur Radiol. 2017 Dec 11. pii: 10.1007/s00330-017-5167.
    PubMed     Text format     Abstract available


    November 2017
  43. MOSHINA N, Roman M, Waade GG, Sebuodegard S, et al
    Breast compression parameters and mammographic density in the Norwegian Breast Cancer Screening Programme.
    Eur Radiol. 2017 Nov 2. doi: 10.1007/s00330-017-5104.
    PubMed     Text format     Abstract available


    October 2017
  44. ZHAO J, Zhang J, Zhu QL, Jiang YX, et al
    The value of contrast-enhanced ultrasound for sentinel lymph node identification and characterisation in pre-operative breast cancer patients: A prospective study.
    Eur Radiol. 2017 Oct 20. doi: 10.1007/s00330-017-5089.
    PubMed     Text format     Abstract available


  45. GIROMETTI R, Zanotel M, Londero V, Linda A, et al
    Automated breast volume scanner (ABVS) in assessing breast cancer size: A comparison with conventional ultrasound and magnetic resonance imaging.
    Eur Radiol. 2017 Oct 10. doi: 10.1007/s00330-017-5074.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: